Mulling It Over 100% FDI allowed in pharma sector through automatic route Seven top Indian firms have been acquired by MNCs in the past six years Fear of price rise in generic medicines if MNCs control market Health, commerce ministries want FDI to go through approvals PMO meeting key ministries next month to take a decision *** Prime Minister Manmohan Singh has always been firm in reminding domestic industry that their fear...
More »SEARCH RESULT
India’s drug ‘lifeline’ under threat by Mari Marcel Thekaekara
I never dreamed I’d ever wave the flag for Indian pharmaceutical companies. But some years ago, I discovered that India provides essential drugs to most of the world’s economically deprived nations. Many of the poorest people in India and Africa could not afford basic drugs if it were not for Indian drug companies. Astonishingly, India is known as the ‘pharmacy to the developing world’ and is something of a hero in...
More »UN hails studies showing antiretroviral drugs can prevent HIV infection
-The United Nations The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS. The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive...
More »UN welcomes pact to improve access of patented AIDS drugs in poor countries
-The United Nations The United Nations agency mandated to spearhead the global response to HIV/AIDS today welcomed the new license agreement between the Medicines Patent Pool and the pharmaceutical company Gilead Sciences to increase access to antiretroviral therapy in developing countries. The Joint UN Programme on HIV/AIDS (UNAIDS) said the agreement marks the first time a pharmaceutical company has signed an agreement with the Medicines Patent Pool, describing it as a turning...
More »"BRICS Can Ensure Affordable Drugs" by Ranjit Devraj
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over. India’s commerce and industry minister Anand Sharma assured Michel Sidibe, chief of the United Nations joint programme on HIV and AIDS (UNAIDS) at a meeting this week that India would reject attempts by pharmaceutical giants to include...
More »